香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全 部 或 任 何 部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Bonjour Holdings Limited 卓悦控股有限公司 （於開曼群島註冊成立之有限公司） （股份代號：653） 自願性公告 關於達成戰略合作計劃之 諒解備忘錄 本公告乃由卓悅控股有限公司（「本公司」，連同其附屬公司，統稱「本集團」）自願作 出，以知會本公司股東（「股東」）及有意投資者有關本集團業務發展之最新消息。 可能合作計劃 本 公 司 董 事（「董 事」）會（「董事會」）欣 然 宣 佈，本 公 司 之 附 屬 公 司 卓 悅 供 應 鏈 管 理 有限公司與紫元元控股集團有限公司（股份代號：8223 ）（「紫元元」）於二零二五年 十二月十一日，就有關本集團可能與紫元元達成的戰略合作計劃（「可能合作計劃」） 訂立不具法律約束力的諒解備忘錄（「諒解備忘錄」），代表協議雙方的初步共識，而 可能合作須待協議雙方訂立正式合作協議方告落實。 ...

Core Viewpoint - Shanghai Pudong New Area has introduced regulations to include the after-sale leasing of medical devices into the regulatory framework, marking a significant step in the management of medical equipment financing leasing [1][3]. Group 1: Regulatory Developments - The first management measures, titled "Several Provisions on the Management of Medical Device Financing Leasing in Pudong New Area," will officially take effect on April 25, 2025 [1]. - The regulations aim to clarify the scope of operations for financing leasing companies, expanding it to cover all types of medical devices, not just large medical equipment [2]. Group 2: Industry Needs - There is a pressing need for differentiated management in the medical device financing leasing sector, as current quality management practices do not meet existing regulatory requirements [2]. - Companies are calling for specific regulatory requirements for the after-sale leasing model, which has seen rapid growth but lacks clear compliance guidelines [2]. Group 3: Innovations in Regulation - The regulations will be the first in the country to include after-sale leasing of medical devices under regulatory oversight, establishing specific quality management requirements for this model [3]. - A differentiated management system will be created, allowing financing leasing companies to collaborate with suppliers and users in managing quality across all stages of medical device leasing [3]. - A cross-departmental supervision and inspection mechanism will be established, enabling shared regulatory information between drug supervision and financing leasing management departments [3].